EP Patent

EP2567690A1 — The use of amisulpride as an anti-emetic

Assigned to Acacia Pharma Ltd · Expires 2013-03-13 · 13y expired

What this patent protects

Amisulpride is used in the therapy of nausea, and vomiting induced by chemotherapy of radiation.

USPTO Abstract

Amisulpride is used in the therapy of nausea, and vomiting induced by chemotherapy of radiation.

Drugs covered by this patent

Patent Metadata

Patent number
EP2567690A1
Jurisdiction
EP
Classification
—
Expires
2013-03-13
Drug substance claim
No
Drug product claim
No
Assignee
Acacia Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.